Unlearn.AI
Platform creating digital twins of clinical trial participants to streamline trials, reduce costs, and improve decision-making.
Community:
Product Overview
What is Unlearn.AI?
Unlearn.AI transforms clinical development by generating digital twins-virtual replicas of trial participants-that enable more efficient and accurate clinical trials. This approach reduces the need for large control groups, accelerates trial timelines, and enhances statistical power without increasing participant numbers. The platform supports diverse stakeholders from biotechs to large pharmaceutical companies by integrating seamlessly with existing infrastructures and maintaining strict data privacy and regulatory compliance. Unlearn.AI’s technology is recognized by regulatory bodies and is advancing clinical trials in neurological and other therapeutic areas.
Key Features
Digital Twins Technology
Creates virtual models of trial participants to simulate clinical outcomes across all future time points, reducing reliance on large control arms.
Trial Efficiency and Cost Reduction
Enables smaller, faster trials by improving statistical power and reducing patient enrollment needs, leading to significant cost savings.
Regulatory Alignment
Methods qualified by the European Medicines Agency and aligned with FDA guidance to support pivotal phase 3 trials.
Flexible Integration
Works with diverse clinical trial infrastructures and data environments, ensuring secure data handling and easy adoption.
Stakeholder Support
Tailors solutions for biotechs, small-mid pharma, and large pharma to meet their unique challenges in clinical development.
Use Cases
- Accelerating Clinical Trials : Speeds up trial timelines by reducing patient recruitment needs and enhancing early decision-making.
- Enhancing Trial Design : Optimizes sample sizes and statistical power through AI-driven simulations, improving trial feasibility and outcomes.
- Supporting Neurological Research : Applied in trials for diseases like ALS and Alzheimer’s to improve efficiency and confidence in results.
- Reducing Development Costs : Lowers overall clinical trial expenses by minimizing control group sizes and shortening study durations.
- Regulatory-Ready Clinical Evidence : Generates data compliant with regulatory standards to support drug approval processes.
FAQs
Unlearn.AI Alternatives
Akido Labs
Healthcare technology company expanding access to quality care through clinical automation and predictive analytics.
Curebase
Comprehensive eClinical platform designed to accelerate clinical trials with integrated solutions for patient engagement, data capture, and study management.
HEALWELL AI
Healthcare AI platform focused on early disease detection and preventative care through advanced clinical decision support systems.
Biobot Analytics
A wastewater analysis platform delivering early, actionable insights on public health threats by monitoring pathogens and chemical substances.
H1
Comprehensive healthcare data platform delivering deep insights on over 11 million healthcare professionals to accelerate clinical trials, medical affairs, and commercial strategies.
Clinikally
India’s digital dermatology platform offering personalized skin and hair treatment plans powered by expert dermatologists and AI-driven recommendations.
SkinSort
Comprehensive skincare app and platform that helps users analyze, compare, and track skincare products and routines with science-backed ingredient insights.
Flexport
End-to-end global supply chain platform delivering visibility, control, and AI-powered logistics solutions from factory to customer door.